Refine by
Biomarker Analysis Articles & Analysis
10 news found
For cell and molecular biology research, R-PE labeled protein can be used as a biomarker in cellular immune analysis, and can also be used as a fluorescent marker in the research of many cells, cell components and related molecules. For Biomedical research, R-PE labeled proteins can be used as fluorescent probes for drug efficacy, biological molecular components, ...
The product manager is pleased to announce the launch of its Microbial Biomarker Discovery service, a revolutionary solution that promises to transform microbiology research. ...
Data from the MANIFEST trial show durable improvements in both spleen volume and symptom score beyond 24 weeks with pelabresib in combination with ruxolitinib for JAK inhibitor-naïve patients An exploratory analysis of biomarkers from the MANIFEST trial indicates the potential for disease modification MorphoSys AG (FSE: MOR; NASDAQ: MOR) today ...
This feature provides a comprehensive, consistent, and automated analysis of biomarkers from next-generation sequencing (NGS) and microarray data that can help clinical researchers stratify therapeutic response across multiple tumor types. ...
New Guardant Reveal™ data from interim analysis of COSMOS-CRC-01 demonstrates high performance for recurrence detection in early-stage colorectal cancer REDWOOD CITY, ...
CD Genomics provides a wide range of services such as genome sequencing, RNA sequencing, epigenomics sequencing, genotyping, as well as integrated portfolios of multiple sequencing services. Integration analysis of multiple sequencing data provides a broader view of the genomics research, which comes extremely handy in gene expression and regulation analysis, ...
Tymora’s focus is on providing diagnostic and therapeutic biomarker discovery contract services and products. Together, they will aim to enrich and measure circulating biomarkers for use in non-invasive early-stage Alzheimer’s Disease(AD) diagnostics and other applications in the global life sciences research and clinical in vitro diagnostics markets. ...
Santa Cruz, CA, September 2018 - SomaGenics announced today the issue of US Patent 10,041,107, a continuation of SomaGenics’ patent family entitled “Methods and Compositions for Detection of small RNAs.” The new patent broads protection for SomaGenics’ innovative, circularization-based approaches to accurately detect and quantify small RNAs, including key ...
"We are excited about bringing BioSystem Development, a valued partner, into Agilent," said Fred Strohmeier, vice president and general manager of Agilent's Liquid Phase Analysis Division within the company's Life Sciences Group. "BioSystem Development's innovative and versatile microchromatography technology, and the team's applications expertise, will help Agilent expand its ...
The cluster will conduct the START (Stroke, imaging, pRevention and Treatment) cohort study of stroke which is designed to integrate imaging and biomarker analysis to identify patients at risk of stroke. Those strategies will then be used to develop preventative measures for those patients. ...